BRAF and melanoma: In this study, we assessed the presence of SDHD promoter mutations and SDHD protein expression in CM, OM and in melanoma cell lines, in which we already determined BRAF, NRAS, GNAQ and TERT promoter mutational status [16, 28, 32].